UBS Group’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06K | Sell |
183
-5,392
| -97% | -$31.1K | ﹤0.01% | 8351 |
|
|
2025
Q1 | $44.6K | Buy |
5,575
+2,269
| +69% | +$18.2K | ﹤0.01% | 6386 |
|
|
2024
Q4 | $35.4K | Buy |
3,306
+1,541
| +87% | +$16.5K | ﹤0.01% | 6285 |
|
|
2024
Q3 | $22.9K | Sell |
1,765
-676
| -28% | -$8.76K | ﹤0.01% | 6083 |
|
|
2024
Q2 | $36.6K | Buy |
2,441
+1,832
| +301% | +$27.5K | ﹤0.01% | 5779 |
|
|
2024
Q1 | $17K | Buy |
609
+226
| +59% | +$6.32K | ﹤0.01% | 5822 |
|
|
2023
Q4 | $8.57K | Buy |
383
+379
| +9,475% | +$8.48K | ﹤0.01% | 6333 |
|
|
2023
Q3 | $89 | Buy |
+4
| New | +$89 | ﹤0.01% | 7763 |
|
|
2022
Q3 | – | Sell |
-126
| Closed | -$5K | – | 9217 |
|
|
2022
Q2 | $5K | Buy |
126
+47
| +59% | +$1.87K | ﹤0.01% | 7804 |
|
|
2022
Q1 | $4K | Buy |
79
+78
| +7,800% | +$3.95K | ﹤0.01% | 8215 |
|
|
2021
Q4 | $0 | Sell |
1
-12
| -92% | – | ﹤0.01% | 9109 |
|
|
2021
Q3 | $3K | Buy |
+13
| New | +$3K | ﹤0.01% | 7642 |
|
|
2021
Q2 | – | Sell |
-23
| Closed | -$15K | – | 8266 |
|
|
2021
Q1 | $15K | Buy |
+23
| New | +$15K | ﹤0.01% | 6593 |
|